Biocept (BIOC) Q4 EPS Beats Consensus, Revenues Beat (Correction)

Go back to Biocept (BIOC) Q4 EPS Beats Consensus, Revenues Beat (Correction)

Biocept (BIOC) Climbs 25% Following Q4 Results

March 29, 2021 4:15 PM EDT

Biocept (NASDAQ: BIOC) Climbs 25% Following Q4 Results

... More